Filter by:
Cardiovascular
September 2024
HFSA Annual Scientific Meeting 2024
CIRRUS-HCM: An Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Effects of EDG-7500 in Adults with Hypertrophic Cardiomyopathy
Cardiovascular
September 2024
HFSA Annual Scientific Meeting 2024
EDG-7500, a First-in-Class Cardiac Sarcomere Modulator, Demonstrates Favorable Tolerability, Safety, and Pharmacokinetics in Healthy Adults
Cardiovascular
September 2024
HFSA Annual Scientific Meeting
CIRRUS-HCM: An Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Effects of EDG-7500 in Adults with Hypertrophic Cardiomyopathy
Cardiovascular
July 2024
AHA Basic Cardiovascular Sciences meeting
Acute Administration of The Novel Cardiac Sarcomere Modulator EDG-7500, Improves Ventricular Filling While Preserving LVEF In Dogs with Pacing Induced Left-Ventricular Systolic Dysfunction
Cardiovascular
April 2024
ACC Annual Scientific Session
Chronic Treatment with the Novel Sarcomere Modulator EDG-7500 Improves Left Ventricular Distensibility and Cardiac Output Recruitment Under Stress in a Mini-pig Genetic Model of Non-Obstructed Hypertrophic Cardiomyopathy
Muscular Dystrophy
April 2024
American Academy of Neurology 2024 Annual Meeting
Effects of Sevasemten (EDG-5506), a Fast Myosin Modulator, on Function and Biomarkers of Muscle Damage in Adults with Becker Muscular Dystrophy
Muscular Dystrophy
March 2024
2024 MDA Annual Clinical and Scientific Conference
Characterization of Short- and Long-Term Proteomic Response to the Fast Skeletal Myosin Inhibitor, EDG-5506, in Becker Muscular Dystrophy (BMD)
Muscular Dystrophy
March 2024
2024 MDA Annual Clinical and Scientific Conference
Functional and Muscle Damage Biomarker Changes Following Treatment with EDG-5506, a Fast Myosin Modulator, in Adults with Becker Muscular Dystrophy
Muscular Dystrophy
March 2024
2024 MDA Annual Clinical and Scientific Conference Industry Forum
